Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 661-672 of 2,301
Drug study icon
CompletedNCT04513912

Seltorexant Compared to Quetiapine XR for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing Seltorexant Compared to Quetiapine XR for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT03321526

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in adults with Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

This study is completed in the United States. It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT03227224

JNJ-42847922 for depression

This study is completed in the United States, in France, in Bulgaria, .... It is testing JNJ-42847922 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
Active Not RecruitingNCT06785012

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

This study is comparing JNJ-89495120 with placebo for people with major depression. Participants receive JNJ-89495120 or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Device study icon
UnknownNCT06329414

Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis

This study is looking at learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS for people with Multiple Sclerosis, depression, or Treatment Resistant Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
University of Utah
Condition
Depression
Drug study icon
CompletedNCT02473289

Sirukumab for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing sirukumab for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 64 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02498392

Safety study of JNJ-42165279 in depression

This study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-42165279 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyDrugFrom 18 Years to 64 Years
Countries
United States, United Kingdom, Moldova, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Anxiety
Drug study icon
WithdrawnNCT05357040

Antidepressant Effects of Nitrous Oxide

This study is comparing Nitrous oxide gas for inhalation with placebo for people with depression or Treatment Resistant Depression. Participants receive Nitrous oxide gas for inhalation or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Australia
Sponsor
University of Chicago
Condition
Depression
Drug study icon
CompletedNCT02153502

AVP-786 for depression

This study is completed in the United States. It is testing AVP-786 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.